Search results for “Epidermal Growth Factor Receptor Inhibitor”

About 1 result in articles

Open Access Pub publishes peer-reviewed, free-to-read open-access articles. Showing articles matching Epidermal Growth Factor Receptor Inhibitor — open any to read the full text, or download the PDF or XML.

1 article
Hematology and Oncology Research Open Access

Erlotinib Associated Trichomegaly in a Patient with Chronic Latanoprost Use

Aug 2015 DOI 10.14302/issn.2372-6601.jhor-15-667

Trichomegaly is a known adverse effect with the epidermal growth factor receptor inhibitor (EGFRI) and prostaglandin analogue drug classes. We present a chronic Latanoprost user who developed symptomatic trichomegaly subsequent to initiating an EGFRI medication and believe this case offers evidence that the two classes of medications may cause a similar eyelash manifestation through different mechanisms.

Read full text PDF XML
Browse more: All journals Journals A–Z By subject

Frequently asked questions

Are these articles peer-reviewed?
Yes. Articles published at Open Access Pub go through single-blind peer review (double-blind on request) under an editorial board before publication.
Are the articles free to read?
Yes. Every article is open access — read the full text online for free and download the PDF or XML, with no paywall or subscription.
How do I cite an article?
Use the DOI shown on each result and on the article page; it is the permanent, citable link to the article.
How do I read or download an article?
Click "Read full text" to open the article HTML, or use the PDF / XML buttons on each card to download it.